STRATA Skin Sciences (SSKN) Cash from Investing Activities Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | STRATA Skin Sciences | - | - | 5.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.21% |
| Sep 30, 2025 | -7.26% |
| Jun 30, 2025 | 19.68% |
| Mar 31, 2025 | 19.70% |
| Dec 31, 2024 | 18.67% |
| Sep 30, 2024 | 31.89% |
| Jun 30, 2024 | 7.81% |
| Mar 31, 2024 | -10.81% |
| Dec 31, 2023 | -27.90% |
| Sep 30, 2023 | 20.36% |
| Jun 30, 2023 | -27.32% |
| Mar 31, 2023 | -34.64% |
| Dec 31, 2022 | -40.71% |
| Sep 30, 2022 | -5.67% |
| Jun 30, 2022 | -6.62% |
| Mar 31, 2022 | -8.21% |
| Dec 31, 2021 | -23.02% |
| Sep 30, 2021 | -74.62% |
| Jun 30, 2021 | -160.95% |
| Mar 31, 2021 | -32.38% |
| Dec 31, 2020 | -5.07% |
| Sep 30, 2020 | 5.67% |
| Jun 30, 2020 | 68.41% |
| Mar 31, 2020 | -42.91% |
| Sep 30, 2019 | -109.60% |
| Jun 30, 2019 | -145.03% |
| Dec 31, 2018 | -9.24% |
| Sep 30, 2018 | 19.61% |
| Jun 30, 2018 | 24.86% |
| Mar 31, 2018 | 24.41% |
| Dec 31, 2017 | 34.16% |
| Sep 30, 2017 | 29.38% |
| Jun 30, 2017 | 9.30% |
| Mar 31, 2017 | -16.69% |
| Dec 31, 2016 | -54.59% |
| Sep 30, 2016 | -58.52% |
| Jun 30, 2016 | 23.68% |
| Mar 31, 2016 | -88.51% |
| Dec 31, 2015 | -102.08% |
| Sep 30, 2015 | -18.22% |